Despite advancements in expanding access to antiretroviral therapy (ART), AIDS-related deaths have plateaued in recent years, and those living with advanced HIV disease (AHD) face a greater risk of death. Those living with AHD represent one-third of all HIV-positive patients in active care. These individuals are more prone to opportunistic infections – including TB severe bacterial infections, and cryptococcal meningitis – that can result in an increased risk of morbidity and mortality. The burden of advanced HIV is significant. Current national strategies and funding priorities do not adequately address the complex issue of advanced HIV disease. Country-specific efforts to curb mortality cannot succeed without appropriate guideline adoption, improvements and innovations in key diagnostic and treatment access and investments in skills of service providers to screen, diagnose and treat advanced HIV. This satellite will explore these barriers but also identify solutions. We'll offer an overview of the clinical and programmatic implications of AHD, globally and discuss a model of successful AHD implementation in Malawi. We'll gather various perspectives on this work and host a panel discussion to chart a path toward successful scaling AHD programming.

• Presentations
• Session recording (English)